Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction (Q38352277)

2 September 2017

Elevated c-Jun expression in acute myeloid leukemias inhibits C/EBPalpha DNA binding via leucine zipper domain interaction (English)

1 reference

2 September 2017

Daniel G Tenen

8

0 references

Torsten Haferlach

7

object named as

Torsten Haferlach

1 reference

2 September 2017

Janki Rangatia

1

1 reference

2 September 2017

Rajani K Vangala

2

1 reference

2 September 2017

Sheo M Singh

3

1 reference

2 September 2017

Abdul A Peer Zada

4

1 reference

2 September 2017

Annika Elsässer

5

1 reference

2 September 2017

Alexander Kohlmann

6

1 reference

2 September 2017

Wolfgang Hiddemann

9

1 reference

2 September 2017

Gerhard Behre

10

1 reference

2 September 2017

language of work or name

English

0 references

publication date

1 July 2003

1 reference

2 September 2017

1 reference

2 September 2017

22

1 reference

2 September 2017

30

1 reference

2 September 2017

4760-4764

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1206664

2 September 2017

0 references

cites work

Ras signaling enhances the activity of C/EBP alpha to induce granulocytic differentiation by phosphorylation of serine 248.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

c-Jun is a JNK-independent coactivator of the PU.1 transcription factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

Reciprocal roles for CCAAT/enhancer binding protein (C/EBP) and PU.1 transcription factors in Langerhans cell commitment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

Acute myeloid leukemias with reciprocal rearrangements can be distinguished by specific gene expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

Absence of granulocyte colony-stimulating factor signaling and neutrophil development in CCAAT enhancer binding protein alpha-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

Mutations in the gene encoding the transcription factor CCAAT/enhancer binding protein alpha in myelodysplastic syndromes and acute myeloid leukemias

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

7 January 2021

McBindall--a better name for CCAAT/enhancer binding proteins?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

7 January 2021

Heterozygous PU.1 mutations are associated with acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

7 January 2021

AML1-ETO downregulates the granulocytic differentiation factor C/EBPalpha in t(8;21) myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

7 January 2021

Dominant-negative mutations of CEBPA, encoding CCAAT/enhancer binding protein-alpha (C/EBPalpha), in acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

7 January 2021

Downregulation of c-Jun expression and cell cycle regulatory molecules in acute myeloid leukemia cells upon CD44 ligation.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

7 January 2021

E2F repression by C/EBPalpha is required for adipogenesis and granulopoiesis in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

7 January 2021

Favorable prognostic significance of CEBPA mutations in patients with de novo acute myeloid leukemia: a study from the Acute Leukemia French Association (ALFA)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

7 January 2021

Granulocyte inducer C/EBPalpha inactivates the myeloid master regulator PU.1: possible role in lineage commitment decisions

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

7 January 2021

The effects of Bcr-Abl on C/EBP transcription-factor regulation and neutrophilic differentiation are reversed by the Abl kinase inhibitor imatinib mesylate

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

7 January 2021

CCAAT/Enhancer binding proteins repress the leukemic phenotype of acute myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

7 January 2021

The myeloid master regulator transcription factor PU.1 is inactivated by AML1-ETO in t(8;21) myeloid leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1206664

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1206664

1 reference

Dimensions Publication ID

2 September 2017

0 references

1 reference